• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword neostem

Total: 50 results found.

1. RxNews Recap for 08-25-10
(Home Page/Home Page)
... manufacturers of electronic components serving the Military, Communication, Medical, Industrial Control and Security Industries. NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international ...
... Hypertension Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome NeoStem Comments on Recent Court Ruling ...
... News Releases in Biotechnology NeoStem Comments on Recent Court Ruling Blocking the Federal Government's Funding of Embryonic Stem Cell Research Reportlinker ...
Company foresees positive impact on its proprietary VSELâ„¢ Technology which uses adult stem cellsNEW YORK, Aug. 25 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), ...
5. Cryo-Cell Making Strategic Moves
(Home Page/Home Page)
The first of only two companies (Cryo-Cell and NeoStem) which generate revenues in the stem cell sector is starting to call attention to itself with back-to-back announcements. Yesterday, Cryo-Cell ...
... candidates demonstrated significant efficacy in the recently completed cell culture studies. NeoStem, Inc. (NYSE Amex:NBS) an international biopharmaceutical company with product and service revenues, ...
7. Neostem's Revenue Base Keeps Rising
(Home Page/Home Page)
NeoStem, Inc. (Amex: NBS) continues to shine as one of  Wall Street's only stem cell sector companies with actual product and service revenues. On Monday, the company announced results of its ...
... to its Corporate Headquarters in Cleveland, Ohio NeoStem Provides Second Quarter Update Other News Releases ...
NEW YORK, Aug. 16 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company")  an international biopharmaceutical company with product and service revenues, global research ...
... for the sale of 700,000 shares of common stock to Seaside 88 every two weeks over the course of a year for a total of up to 18,200,000 shares of MannKind common stock. NeoStem, Inc. (NYSE Amex:NBS) an ...
... News Releases in Biotechnology Fibrocell Science, Inc. to Present at the 2010 Global Hunter Securities Healthcare Conference NeoStem and the Schepens ...
NEW YORK, Aug. 11 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today ...
... News Releases in Biotechnology NeoStem to Present at Two Industry Conferences This Week Generex Oncology Names Dr. Craig Eagle to its Scientific ...
NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced ...
... News Releases in Biotechnology Tel Aviv University Research on the Mechanism of Copper Transport Into Human Cells may Enhance Chemotherapy NeoStem ...
... for XOMA 052 for the same indication in the European Union. Shares of XOMA jumped as much as 40% in early trading before paring back some of its gains and closing the day at 32 cents, up 15.48%. NeoStem, ...
Dr. Thomas Einhorn has Clinical Experience Using Innovative Adult Stem Cell Therapies for Orthopedic AilmentsNEW YORK, Aug. 4 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), ...
... News Releases in Biotechnology NeoStem Adds Distinguished Orthopaedic Surgeon to its Medical Advisory Board American Oriental Bioengineering to ...
... News Releases in Health Care & Hospitals NeoStem Adds Distinguished Orthopaedic Surgeon to its Medical Advisory Board Wireless Health 2010 Assembles ...
... News Releases in Biotechnology NeoStem Adds Distinguished Orthopaedic Surgeon to its Medical Advisory Board Dyadic International Announces ...
... coverage on NeoStem (NYSE Amex: NBS) with a recommended buy rating. According to Rob Goldman, senior research analyst, NeoStem has already begun to successfully leverage its Suzhou Erye operations and ...
... interview with Jeffrey Davis, CEO of Access Pharmaceuticals here. Sources are telling us that Neostem (AMEX:NBS) may be getting positive coverage by at least one analyst in the days ahead and that could ...
Marketwire HOUSTON, TX--(Marketwire - July 21, 2010) - Adult stem cell leader Neostem, Inc. (NYSE Amex:Ticker=NBS">NBS) has been awarded a $700,000 military grant from the U.S. Army's Medical ...
24. News could help shares bounce
(Premium Content/Subscriber Only Content)
We are hearing a lot of chatter that New York-based NeoStem, who is engaged in the development of stem cell-based therapies and is building of a network of adult stem cell collection centers in the U.S. ...
As if a nod of endorsement from the Vatican weren't enough, today NeoStem, Inc. (NYSE Amex: NBS) announced that it has been awarded a $700,000 contract from the U.S. Army Medical Research and Materiel ...
... News Releases in Biotechnology BioStorage Technologies Appoints New Global Director of Marketing to Spearhead Corporate Marketing Strategy NeoStem ...
NEW YORK, July 12 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced ...
... News Releases in Biotechnology NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic ...
... News Releases in Biotechnology NeoStem to Present at the Global Hunter Securities China Conference in San Francisco on July 11 - 13, 2010 American ...
... News Releases in Health Care & Hospitals NeoStem to Present at the Global Hunter Securities China Conference in San Francisco on July 11 - 13, 2010 Nation's ...
... News Releases in Biotechnology NeoStem to Present at the Global Hunter Securities China Conference in San Francisco on July 11 - 13, 2010 American ...
NEW YORK, July 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced ...
33. News Recap for Tuesday 07-06-10
(Home Page/Home Page)
... the company as Executive Vice President and Chief Medical Officer effective immediately, with responsibility for leading the company's global development, clinical and medical initiatives. NeoStem, Inc. ...
NeoStem, Inc. (NYSE Amex: NBS) has been selected as the "Best Stem Cell Company, 2010" in The New Economy's Biotech Awards, which identify excellence in the field of technology. The respected U.K. ...
NEW YORK -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that it has been selected for ...
... Industry: A Technology, Industry and Market Analysis NeoStem Named 'Best Stem Cell Company' in The New Economy's 2010 Biotech Awards Biostar ...
... Industry: A Technology, Industry and Market Analysis NeoStem Named 'Best Stem Cell Company' in The New Economy's 2010 Biotech Awards Novavax ...
... shares of the common stock of Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV). NeoStem, Inc. (NYSE Amex: NBS) announced that it has appointed Roberto Bolli, M.D., to its Scientific Advisory Board. Dr. ...
... New Members to Its Board of Directors NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board Other ...
... Three New Members to Its Board of Directors NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board Other ...
-- Dr. Roberto Bolli brings unmatched VSEL research expertise in the cardio niche ---- Will help guide NeoStem's exciting VSEL(TM) technology R&D efforts --NEW YORK, July 1 /PRNewswire-Asia-FirstCall/ ...
... eC-SSRS is an Effective Method of Suicidality Monitoring in Clinical Trials NeoStem to Present at OneMedForum Emerging Company Finance Conference  ...
... Linear Amplification Technology Enables Successful International Clinical Genetic Study of Single Human Cells NeoStem to Present at OneMedForum Emerging Company Finance ...
NEW YORK, June 30 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced ...
... tumors in animal models. Unlike the monoclonal antibody cetuximab, the cetuximab-based BiTE antibody did not show evidence of skin toxicity usually attributed to anti-EGFR therapies. NeoStem, Inc. (NYSE ...
If you don't follow the company closely, you may not realize the significance of today's news announcement from NeoStem (AMEX:NBS), but the details are definitely worth noting. NBS announced today that ...
LOS ANGELES, CA-- Neostem (NYSE Amex: NBS) announced today that its Suzhou Erye pharmaceutical subsidiary in China passed government inspection by that country's State Food and Drug Administration and ...
... News Releases in Biotechnology Data Published in Proceedings of National Academy of Sciences Highlights Potential of Micromet's BiTE Antibody Platform NeoStem ...
Move increases production capacity by more than 50% for significant revenue generating antibioticsNEW YORK, June 29 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. ("NeoStem" or the "Company") (NYSE Amex: ...
... News Releases in Biotechnology NeoStem Pharmaceutical Subsidiary Announces Two cGMP Lines are Now Fully Operational in New Facility Vermillion ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved